Presumably three years ago there was not much more than a couple of preclinical studies and the first phase one. Things seem to have moved on from then don't you think. The rhetoric from the company albeit in self interest is quite the opposite to your views. Perhaps the two new directors are wasting their time...
Ann: Shareholder Update , page-26
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
